Trial no.:
|
PACTR202001789968542 |
Date of Approval:
|
15/01/2020 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Analgesic effect of addition of pecto-intercostal block to serratus anterior plane block in breast surgeries: A Randomized controlled trial
|
Official scientific title |
Analgesic effect of addition of pecto-intercostal block to serratus anterior plane block in breast surgeries: A Randomized controlled trial
|
Brief summary describing the background
and objectives of the trial
|
Ultrasound-guided interfascial plane blocks are considered one of the recent modalities for effective perioperative analgesia in breast surgeries. The serratus anterior plane block (SAPB) has been used effectively and safely for the management of perioperative pain for breast surgeries.
SAPB cannot block effectively the anterior cutaneous branches of the intercostal nerves and do not provide adequate analgesia near the sternum and in the inner quadrant of the breast, thus new blocks have been developed to overcome this issue, for example, pectointercostal fascial plane block (PIFB).
The pecto-intercostal fascial block (PIFB) consists of injecting a local anesthetic (LA) between the pectoralis major muscle and the external intercostal muscle to block the anterior cutaneous branches of the intercostal nerves that penetrate through these two muscles to innervate the internal mammary area.
The aim of the study is to evaluate the role of PIFB as a supplement to SAPB. The primary outcome of this study is to evaluate the use of pectointercostal plane block in addition to SAPB on the total opioid consumption and on the postoperative pain score. The secondary outcome is intra- and post-operative hemodynamic stability.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
15/02/2020 |
Actual trial start date |
|
Anticipated date of last follow up |
15/08/2020 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
40 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|